Chronic Idiopathic Urticaria (CIU) Treatment Market is segmented By Route of Administration (Subcutaneous, Intravenous, Oral), By Molecule Type (Monoclonal Antibody, Small Molecule, Recombinant Fusion Proteins), By Product Type (Mono, Combination), By Development Phase (Phase I, Phase II, Phase III), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Chronic Idiopathic Urticaria (CIU) Treatment Market is segmented By Route of Administration (Subcutaneous, Intravenous, Oral), By Molecule Type (Monoc....